"We felt we didn't have sufficient funding to finish the [pivotal U.S.] trial and you don't want to put hospitals in an uncomfortable position."

— Mark Tauscher, president/CEO of PLC Systems, on his company's decision to delay the start of a pivotal trial for one of its products under development, "PLC delays pivotal trial for RenalGuard system," pp. 1, 7.